Ke. Helmick et al., DISPOSITION OF SINGLE-DOSE INTRAVENOUSLY ADMINISTERED ENROFLOXACIN INEMUS (DROMAIUS-NOVAEHOLLANDIAE), Journal of zoo and wildlife medicine, 28(1), 1997, pp. 43-48
The pharmacokinetics of enrofloxacin in emus (Dromaius novaehollandiae
) were examined following parenteral administration. A mean allometric
ally scaled dose of 2.2 +/- 0.03 mg/kg was administered as a single i.
v. bolus, and serum samples were collected at predetermined intervals
over a 24-hr period. Enrofloxacin levels were measured using high-perf
ormance liquid chromatography, and the resulting concentration versus
time curve was analyzed using nonlinear regression with least squares
parameter estimation. The data were best represented by a two-compartm
ent model with a mean elimination half-life of 3.33 hr. Mean model ind
ependent parameters obtained were area under the curve (8.26 mu g.hr/m
l), mean residence time (4.40 hr), apparent volume of distribution (1.
49 L/kg), and total body drug clearance (0.36 L/hr/kg). Mean serum con
centrations exceeded the target peak of 2.0 mu g/ml and remained above
an estimated inhibitory concentration of 0.5 mu g/ml for approximatel
y 2 hr. Based upon the results of this study, enrofloxacin administere
d parenterally to emus at 2.2 mg/kg every 12 hr is expected to achieve
therapeutic serum concentrations against susceptible organisms.